Graham Svoronos

(Ms. Dawn Svoronos)

Currently holds positions in PTC Therapeutics Inc, Xenon Pharmaceuticals Inc and Global Blood Therapeutics Inc

Positions
Position Company Period
Independent Director PTC Therapeutics Inc June 13, 2016 -
Independent Director Xenon Pharmaceuticals Inc Sept. 27, 2016 -
Independent Director Global Blood Therapeutics Inc Dec. 19, 2018 -
Director Endocyte Inc None -
Independent Director Medivation Inc Dec. 1, 2014 - Sept. 28, 2016
Interim Chief Commercial Officer, Director Medivation Inc July 10, 2014 - Dec. 1, 2014
Independent Director Medivation Inc April 1, 2013 - July 10, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
Aug. 24, 2023 Aug. 24, 2023
S Sale
25,000 -50.0%
38.70
967,500 USD 		25,000 -50.0% 38.70 967,500 USD
May 18, 2022 May 16, 2022
B Purchase
30,000 +150.0%
0.85
25,578 USD 		30,000 +150.0% 0.85 25,578 USD
April 1, 2021 March 31, 2021
B Purchase
20,000 +inf%
10.02
200,338 USD 		20,000 +inf% 10.02 200,338 USD

Modal body text goes here.